Circulating cytokine levels in osteoporotic and normal women

Sundeep Khosla, James M. Peterson, Kathleen Egan, James D. Jones, B. Lawrence Riggs

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Interleukin-1 (IL-1) and IL-6 have been postulated to play roles in the pathogenesis of postmenopausal osteoporosis. To test this hypothesis, we measured circulating levels of IL-6, IL-1α, and IL-1β in 40 age-matched normal and 40 osteoporotic women with vertebral fractures and increased bone turnover. Since IL-1 activity is modulated by the IL-1 receptor antagonist (IL-1ra), we also measured circulating IL-1ra levels in these women. Despite having higher rates of bone turnover as assessed by bone biochemical markers, the osteoporotic women had serum levels of IL-6, IL-1α, and IL-1β that were similar to the normal women. IL-1ra levels (mean ± SEM) tended to be lower in the osteoporotic women (143 ± 21 pg/mL) vs. the normal women (189 ± 22 pg/mL; P = 0.08). The IL-1α/IL-1ra ratio, an index of IL-1α bioactivity, was higher in the osteoporotic women (6.4 ± 1.1) than in the normal women (4.4 ± 0.5; P < 0.05). There were nonsignificant trends for increased IL- 1β/IL-1ra and (IL-1α + IL-1β)/IL-1ra ratios in the osteoporotic vs. normal women. None of the cytokines correlated with markers of bone resorption in either group of women. In summary, although there was a trend for a higher IL-1/IL-1ra ratio in the osteoporotic women, we were unable to demonstrate unequivocal abnormalities of cytokines affecting bone resorption in peripheral serum of women with postmenopausal osteoporosis. However, it is possible that increased production of these cytokines occurs in the local environment of bone or bone marrow and is not detected by analysis of peripheral serum. Thus, further studies will be required to exclude this possibility.

Original languageEnglish (US)
Pages (from-to)707-711
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume79
Issue number3
DOIs
StatePublished - Sep 1994

Fingerprint

Interleukin-1
Interleukin-1 Receptors
Cytokines
Bone
Interleukin-6
Postmenopausal Osteoporosis
Bone Remodeling
Bone Resorption
Serum
Bone and Bones
Bioactivity
Biomarkers
Bone Marrow
Scanning electron microscopy

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Circulating cytokine levels in osteoporotic and normal women. / Khosla, Sundeep; Peterson, James M.; Egan, Kathleen; Jones, James D.; Riggs, B. Lawrence.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 79, No. 3, 09.1994, p. 707-711.

Research output: Contribution to journalArticle

Khosla, Sundeep ; Peterson, James M. ; Egan, Kathleen ; Jones, James D. ; Riggs, B. Lawrence. / Circulating cytokine levels in osteoporotic and normal women. In: Journal of Clinical Endocrinology and Metabolism. 1994 ; Vol. 79, No. 3. pp. 707-711.
@article{8861b347d2374c3db0753d122c182257,
title = "Circulating cytokine levels in osteoporotic and normal women",
abstract = "Interleukin-1 (IL-1) and IL-6 have been postulated to play roles in the pathogenesis of postmenopausal osteoporosis. To test this hypothesis, we measured circulating levels of IL-6, IL-1α, and IL-1β in 40 age-matched normal and 40 osteoporotic women with vertebral fractures and increased bone turnover. Since IL-1 activity is modulated by the IL-1 receptor antagonist (IL-1ra), we also measured circulating IL-1ra levels in these women. Despite having higher rates of bone turnover as assessed by bone biochemical markers, the osteoporotic women had serum levels of IL-6, IL-1α, and IL-1β that were similar to the normal women. IL-1ra levels (mean ± SEM) tended to be lower in the osteoporotic women (143 ± 21 pg/mL) vs. the normal women (189 ± 22 pg/mL; P = 0.08). The IL-1α/IL-1ra ratio, an index of IL-1α bioactivity, was higher in the osteoporotic women (6.4 ± 1.1) than in the normal women (4.4 ± 0.5; P < 0.05). There were nonsignificant trends for increased IL- 1β/IL-1ra and (IL-1α + IL-1β)/IL-1ra ratios in the osteoporotic vs. normal women. None of the cytokines correlated with markers of bone resorption in either group of women. In summary, although there was a trend for a higher IL-1/IL-1ra ratio in the osteoporotic women, we were unable to demonstrate unequivocal abnormalities of cytokines affecting bone resorption in peripheral serum of women with postmenopausal osteoporosis. However, it is possible that increased production of these cytokines occurs in the local environment of bone or bone marrow and is not detected by analysis of peripheral serum. Thus, further studies will be required to exclude this possibility.",
author = "Sundeep Khosla and Peterson, {James M.} and Kathleen Egan and Jones, {James D.} and Riggs, {B. Lawrence}",
year = "1994",
month = "9",
doi = "10.1210/jc.79.3.707",
language = "English (US)",
volume = "79",
pages = "707--711",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Circulating cytokine levels in osteoporotic and normal women

AU - Khosla, Sundeep

AU - Peterson, James M.

AU - Egan, Kathleen

AU - Jones, James D.

AU - Riggs, B. Lawrence

PY - 1994/9

Y1 - 1994/9

N2 - Interleukin-1 (IL-1) and IL-6 have been postulated to play roles in the pathogenesis of postmenopausal osteoporosis. To test this hypothesis, we measured circulating levels of IL-6, IL-1α, and IL-1β in 40 age-matched normal and 40 osteoporotic women with vertebral fractures and increased bone turnover. Since IL-1 activity is modulated by the IL-1 receptor antagonist (IL-1ra), we also measured circulating IL-1ra levels in these women. Despite having higher rates of bone turnover as assessed by bone biochemical markers, the osteoporotic women had serum levels of IL-6, IL-1α, and IL-1β that were similar to the normal women. IL-1ra levels (mean ± SEM) tended to be lower in the osteoporotic women (143 ± 21 pg/mL) vs. the normal women (189 ± 22 pg/mL; P = 0.08). The IL-1α/IL-1ra ratio, an index of IL-1α bioactivity, was higher in the osteoporotic women (6.4 ± 1.1) than in the normal women (4.4 ± 0.5; P < 0.05). There were nonsignificant trends for increased IL- 1β/IL-1ra and (IL-1α + IL-1β)/IL-1ra ratios in the osteoporotic vs. normal women. None of the cytokines correlated with markers of bone resorption in either group of women. In summary, although there was a trend for a higher IL-1/IL-1ra ratio in the osteoporotic women, we were unable to demonstrate unequivocal abnormalities of cytokines affecting bone resorption in peripheral serum of women with postmenopausal osteoporosis. However, it is possible that increased production of these cytokines occurs in the local environment of bone or bone marrow and is not detected by analysis of peripheral serum. Thus, further studies will be required to exclude this possibility.

AB - Interleukin-1 (IL-1) and IL-6 have been postulated to play roles in the pathogenesis of postmenopausal osteoporosis. To test this hypothesis, we measured circulating levels of IL-6, IL-1α, and IL-1β in 40 age-matched normal and 40 osteoporotic women with vertebral fractures and increased bone turnover. Since IL-1 activity is modulated by the IL-1 receptor antagonist (IL-1ra), we also measured circulating IL-1ra levels in these women. Despite having higher rates of bone turnover as assessed by bone biochemical markers, the osteoporotic women had serum levels of IL-6, IL-1α, and IL-1β that were similar to the normal women. IL-1ra levels (mean ± SEM) tended to be lower in the osteoporotic women (143 ± 21 pg/mL) vs. the normal women (189 ± 22 pg/mL; P = 0.08). The IL-1α/IL-1ra ratio, an index of IL-1α bioactivity, was higher in the osteoporotic women (6.4 ± 1.1) than in the normal women (4.4 ± 0.5; P < 0.05). There were nonsignificant trends for increased IL- 1β/IL-1ra and (IL-1α + IL-1β)/IL-1ra ratios in the osteoporotic vs. normal women. None of the cytokines correlated with markers of bone resorption in either group of women. In summary, although there was a trend for a higher IL-1/IL-1ra ratio in the osteoporotic women, we were unable to demonstrate unequivocal abnormalities of cytokines affecting bone resorption in peripheral serum of women with postmenopausal osteoporosis. However, it is possible that increased production of these cytokines occurs in the local environment of bone or bone marrow and is not detected by analysis of peripheral serum. Thus, further studies will be required to exclude this possibility.

UR - http://www.scopus.com/inward/record.url?scp=0027935394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027935394&partnerID=8YFLogxK

U2 - 10.1210/jc.79.3.707

DO - 10.1210/jc.79.3.707

M3 - Article

C2 - 8077350

AN - SCOPUS:0027935394

VL - 79

SP - 707

EP - 711

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -